From a medical cardiologist’s perspective, how do the threshold-setting targets of LDL-C levels of 70 mg/dL apply to PCSK9-based treatment for CV risk reduction? Did the guidelines emphasize sufficiently, the results of the CV outcome trials?

Name: From a medical cardiologist’s perspective, how do the threshold-setting targets of LDL-C levels of 70 mg/dL apply to PCSK9-based treatment for CV risk reduction? Did the guidelines emphasize sufficiently, the results of the CV outcome trials?
Uploaded: 2019-03-11T00:00:00+00:00

CLICK HERE FOR CME CREDIT

Created by

Presenter

R. Scott Wright, MD

Professor of Medicine
Department of Cardiovascular Medicine
Cardiovascular Division
Mayo Clinic